PT-141 (bremelanotide) research peptide in Canada

At a glance

Material class

melanocortin receptor agonist peptide

Catalog category

sexual health

Molecular confirmation

Verified by MS

Appearance

Lyophilised powder; inspect vial and COA before use

Primary research themes

MC3R/MC4R signalling and reproductive-endocrine models

PT-141 documentation checks before ordering

• The linked certificate reports 99.39% purity for lot LNX-2507-2613 only. Its Lynx Labs branding does not independently identify an external testing laboratory.
• Lyophilised vial format supports controlled storage, reconstitution, and aliquoting workflows.
• Mass confirmation and chromatographic identity checks are used to support batch traceability.
• Canadian shipping and clear labelling help research teams keep custody records organized.

Primary target context

Research teams usually evaluate PT-141 through MC3R/MC4R signalling and reproductive-endocrine models. Experimental interpretation should start with the intended receptor, enzyme, binding partner, or formulation role before comparing outcome markers.

Downstream signalling

Downstream readouts for PT-141 depend on the model system, but commonly include pathway activation markers, transcript or protein expression, tissue histology, and time-course response compared with vehicle controls.

Model selection

In-vitro assays can isolate binding or signalling behaviour, while rodent or ex-vivo models may capture tissue-level response. Study design should separate compound-specific effects from diluent, handling, and batch variables.

Controls and limitations

Because PT-141 is supplied as a research material, interpretation depends on validated controls, documented storage, matched vehicle arms, and batch-specific COA review. Avoid extrapolating model findings outside the study design.

Before reconstitution

• Keep sealed vials cold, dry, and protected from light until use.
• Allow the vial to equilibrate before opening to reduce condensation on the stopper or cake.
• Inspect label, lot number, cake appearance, and COA before assigning the material to a study.

Reconstitution

• Use sterile diluent compatible with the study design and the product-specific handling sheet.
• Introduce diluent slowly down the vial wall and swirl gently until dissolved.
• Record concentration, diluent, operator, date, and any deviations in the lab notebook.

After reconstitution

Short-term

2–8 °C, protected from light, using aseptic handling.

Long-term

Store lyophilised material at freezer conditions unless the COA or handling sheet states otherwise.

Freeze / thaw

Avoid repeated freeze-thaw cycles; aliquot when validated by the protocol.

Fields on the reviewed PT-141 certificate

• Lot LNX-2507-2613, printed with a leading #; match it to the received vial label.
• Method heading: HPLC-UV coupled with mass spectrometry; chromatogram and mass-spectrometry panels are displayed.
• Reported date: 2025-07-12. The footer also uses LC-MS/MS wording; ask for method clarification if required by your laboratory.
• Appearance: white lyophilized powder. Do not infer unreported solubility, sterility, endotoxin or moisture results.
• Archive the certificate and retrieval date with the receiving record.

PT-141 vs. Melanotan-2

PT-141 is positioned around melanocortin research, while Melanotan-2 is typically cross-shopped for a related but distinct research angle. Select between them by receptor/pathway target, literature model, handling requirements, and whether the study design needs a single compound or a comparative arm.